Role of the CCR5Δ32 allele in resistance to HIV-1 infection in West Africa

Journal of Human Virology

Volumn 1, Issue 7, 1998, Pages 469-474

  Kokkotou, Efi ^a   Philippon, Valerie ^a   Guèye Ndiaye, Aïssatou ^b   Mboup, Souleymane ^b   Wang, Wei Kung ^a   Essex, Max ^a   Kanki, Phyllis ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

Africa; AIDS; CCR5 32; HIV 1

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PROSTITUTION; RISK FACTOR; SENEGAL; SERODIAGNOSIS; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HIV SERONEGATIVITY; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PROSTITUTION; RECEPTORS, CCR5; RISK FACTORS; SENEGAL;

EID: 0032195802     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. + T cells. Science 1995;270:1811-1815.
2. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
3. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661-666.
4. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
5. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86: 367-377.
6. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCr-5 chemokine receptor gene. Nature 1996;382: 722-725.
7. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273:1856-1862.
8. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet 1997;16:100-103.
9. Carrington M, Kissner T, Gerrarf B, Ivanov S, Obrien SJ, Dean M. Novel alleles of the chemokine receptor gene CCR5. Am J Hum Genet 1997;61:126l-1267.
10. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
11. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997;3:23-36.
12. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997;3:338-340.
13. Eugen-Olsen J, Iversen AK, Garred P, et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals. AIDS 1997;11: 305-310.
14. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR5Δ32 Heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997;11: F73-F78.
15. de Roda Husman AM, Koot M, Cornelisśen M, et la. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997;127:882-890.
16. Garred P. Chemokine receptor polymorphisms: clarity or confusion for HIV-1 prognosis? Lancet 1998;251:2-3.
17. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-965.
18. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-1590.
19. Kanki PJ, Travers KU, Mboup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-946.
20. Travers K, Mboup S, Marlink R, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995; 268:1612-1615.
21. + lymphocyte counts. AIDS 1998;12:131-137.
22. Quillent C, Oberlin E, Braun J, et al. HIV-1 resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998;351:14-18.
23. Lu C, Williams T, Makuwa M, et al. Analysis of genetic polymorphism of the HIV-1 coreceptor (CCR5 locus) in a Gabonese population [abstract 044A297]. Presented at the Xth International Conference on AIDS and STD in Africa, Abidjan, December 1997.
24. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Med 1996;2:412-417.
25. Aarons E, Fernandex M, Rees A, McClure M, Weber J. CC-chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV-exposed uninfected homosexual men. AIDS 1997;11:688-689.
26. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectibility by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1691.
27. Zhang L, Huang Y, He T, Cao Y, Ho D. HIV-1 subtype and second receptor use. Nature 1996;383:768.
28. Zagury D, Lachgar A, Chams V, et al. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A 1998;95:3857-3861.
29. Benkirane M, Jin D, Chun R, et al. Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. J Biol Chem 1997;272:30603-30606.